Involvement of protein binding inhibition in dexmedetomidine concentration change in ECMO circuits during midazolam use
Keishi Yamasaki、Koji Nishi、Kenji Tsukigawa、Masaki Otagiri、Yuhki Sato
Study of the Inclusion Complexes Formed Between 4-Phenylbutyrate and α-, β-, and γ-Cyclodextrin in Solution and Evaluation on Their Taste-Masking Properties
Kindness Commey、Akari Nakatake、Airi Enaka、Koji Nishi、Kenji Tsukigawa、Koki Yamaguchi、Hirohito Ikeda、Daisuke Iohara、Fumitoshi Hirayama、Masaki Otagiri、Keishi Yamasaki
7-phenyl heptanoic acid ameliorates chronic kidney disease through the suppression of indoxyl sulfate production
Kindness Commey, Akari Nakatake, Airi Enaka, Ryota Nakamura, Kenji Tsukigawa, Koji Nishi, Masaki Otagiri, Keishi Yamasaki
日本薬物動態学会第37回年会 2022/11/7-10
Effects of myristate on the induced circular dichroism spectra of aripiprazole bound to human serum albumin: A structural-chemical investigation
Masaki Otagiri, Kenshiro Hirata, Akito Kawai, Victor Tuan Giam Chuang, Keiki Sakurama, Koji Nishi, Keishi Yamasaki
Structural basis of the change in the interaction between mycophenolic acid and subdomain IIA of human serum albumin during renal failure
Keishi Yamasaki, Honoka Teshima, Reina Yukizawa, Koki Kuyama, Kenji Tsukigawa, Koji Nishi, Masaki Otagiri, Akito Kawai
Masking the foul taste of 4-phenylbutyrate to improve compliance: the case of cyclodextrin complexation
Kindness Commey、中武 灯、江中 愛莉、西 弘二、月川 健士、池田 浩人、庵原 大輔、平山 文俊、小田切 優樹、山崎 啓之
Possible roles of intestinal P-glycoprotein and cytochrome P450 3A on the limited oral absorption of irinotecan.
Keishi Yamasaki, Muneaki Hidaka, Yohei Kawano, Yumiko Furuya, Hiroshige Ono, Kazuhiko Arimori
16th World Nano Conference June 5-6, 2017, Milan, Italy
S-Nitrosated human serum albumin dimer with superior antitumor activity,
long blood retention and excellent EPR effect
Masaki Otagiri, Yu Ishima, Toru Maruyama
6th FIP Pharmaceutical Sciences World Congress (PSWC) Stockholm, Sweden
21-24 May 2017
Preparation of albumin-encapsulated liposome as a novel DDS carrier
Yuko Okamoto, Kazuaki Taguchi, Keishi Yamasaki, Mina Sakuragi, Shun'ichi
Kuroda, Masaki Otagiri
Pharmacokinetics analysis of novel candidate drugs against hepatic B virus
Mai Hashimoto, Kazuaki Taguchi, Takako Ishiguro, Keishi Yamasaki, Satoru
Kohgo, Hiroaki Mitsuya, Masaki Otagiri
Preparation and evaluation of doxorubicin-loaded human serum albumin nanoparticles
Kotaro Kimura, Keishi Yamasaki, Kazuaki Taguchi, Hideaki Nakamura, Mamoru
Haratake, Masaki Otagiri
Therapeutic efficacy and safety of long-term stored hemoglobin-vesicles
in a rat model of hemorrhagic shock
Masahiro Tokuno, Kazuaki Taguchi, Keishi Yamasaki, Hiromi Sakai, Masaki
Otagiri
Biological responsiveness and pharmacokinetic properties of cellular type
hemoglobin based oxygen carrier (Hemoglobin-Vesicles) in hyperlipidemia
model mice after massive intravenous injection
Kazuaki Taguchi, Keishi Yamasaki, Hiromi Sakai, Toru Maruyama, Masaki Otagiri
International Conference On Nanomedicine And Nanobiotechnology – ICONAN
2016, Sept 28-30, 2016 (Université Pierre et Marie Curie, Paris)
Albumin as Nitric Oxide-Traffic Protein : Novel Anticancer Agent
Masaki Otagiri, Yu Ishima, Toru Maruyama
International Nanomedicine Conference 2016/6/27-29 (Crowne Plaza Hotel
at Coogee Beach, Sydney, Australia)
Erythropoietin-encapsulated liposomes targeted to bone marrow: Preparation
and In vitro and In vivo hematopoietic evaluation
Kazuaki Taguchi, Toru Maruyama, Keitaro Sou, Masaki Otagiri